Urticaria Activity Score – Prof. Marcus Maurer

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines

412.

Agache, I.⁺, Rocha, C., Pereira, A., Song, Y., Alonso-Coello, P., Solà, I., Beltran, J., Posso, M., Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger, T., Eyerich, K., Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P., O’Mahony, L., Schwarze, J., Werfel, T., Canelo-Aybar, C., Palomares, O., and Jutel, M.: Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines. Allergy 2021: 76; 59-70. IF: 14.71

o.412

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines Read More »

Comparison and interpretability of the available urticaria activity scores

mm-red

291	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Comparison and interpretability of the available urticaria activity scores. Allergy 2018: 73; 251-255. IF: 6.77

Comparison and interpretability of the available urticaria activity scores Read More »

Diagnosis of urticaria

mm-red

74.	Schoepke, N., Doumoulakis, G., and Maurer, M.: Diagnosis of urticaria. Ind. J. Dermatology 2013: 58; 211-218. IF: N/A

Diagnosis of urticaria Read More »

Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen

mm-red

104.

Weller, K., Peveling-Oberhag, A., Altrichter, S., Schoepke, N., Abajian, M., Zuberbier, T., Staubach, P., and Maurer, M.: Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen. Allergologie 2016: 39; 6-15. IF: 0.31

r.104

Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen Read More »

IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J

mm-red

325	Schmetzer, O.+, Lakin, E., Topal, F. A., Preusse, P., Freier, D., Church, M. K., and Maurer, M.: IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J. Allergy Clin. Immunol. 2018: 142; 876-882. IF: 14.11)

IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Read More »

The urticaria activity score – validity, reliability, and responsiveness

mm-red

322	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: The urticaria activity score – validity, reliability, and responsiveness. J. Allergy Clin. Immunol. Pract. 2018: 6; 1185-1190. IF: 7.55

The urticaria activity score – validity, reliability, and responsiveness Read More »

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria

mm-red

172

Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., Baiardini, I., Panagiotakos, D., Braido, F., and Maurer, M.+: Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013: 226; 371-379. IF: 1.68

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria Read More »